D&D Pharmatech

D&D Pharmatech is a clinical-stage global biotechnology company that funds the development of revolutionary drugs through disease-specific subsidiaries founded and led by top medical researchers. This corporate structure creates a unique opportunity to accelerate the translation of cutting-edge research into life-saving therapeutic products. The company's pipeline focuses on a range of indications, including neurodegenerative diseases, fibrosis, and metabolic disorders. D&D Pharmatech is the parent company of U.S.-based Neuraly Inc., Theraly Fibrosis Inc., Precision Molecular Inc., P4Microbiome, and Valted Seq, Inc.